NO179046C - Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator - Google Patents

Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator

Info

Publication number
NO179046C
NO179046C NO881615A NO881615A NO179046C NO 179046 C NO179046 C NO 179046C NO 881615 A NO881615 A NO 881615A NO 881615 A NO881615 A NO 881615A NO 179046 C NO179046 C NO 179046C
Authority
NO
Norway
Prior art keywords
plasminogen activator
preparation
biologically active
single chain
urokinase type
Prior art date
Application number
NO881615A
Other languages
English (en)
Norwegian (no)
Other versions
NO881615D0 (no
NO179046B (no
NO881615L (no
Inventor
Bernd Meyhack
Jutta Heim
Rolf Burgi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878709081A external-priority patent/GB8709081D0/en
Priority claimed from IE329987A external-priority patent/IE81116B1/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO881615D0 publication Critical patent/NO881615D0/no
Publication of NO881615L publication Critical patent/NO881615L/no
Publication of NO179046B publication Critical patent/NO179046B/no
Publication of NO179046C publication Critical patent/NO179046C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO881615A 1987-04-15 1988-04-14 Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator NO179046C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878709081A GB8709081D0 (en) 1987-04-15 1987-04-15 Production of proteins
GB878714059A GB8714059D0 (en) 1987-04-15 1987-06-16 Production of proteins
IE329987A IE81116B1 (en) 1986-12-05 1987-12-04 Hybrid plasminogen activators

Publications (4)

Publication Number Publication Date
NO881615D0 NO881615D0 (no) 1988-04-14
NO881615L NO881615L (no) 1988-10-17
NO179046B NO179046B (no) 1996-04-15
NO179046C true NO179046C (no) 1996-07-24

Family

ID=27263391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881615A NO179046C (no) 1987-04-15 1988-04-14 Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator

Country Status (18)

Country Link
US (1) US5175105A (de)
EP (1) EP0288435B1 (de)
JP (1) JP2894696B2 (de)
AT (1) ATE102994T1 (de)
AU (1) AU604305B2 (de)
CA (1) CA1341306C (de)
DD (1) DD274053A5 (de)
DE (1) DE3888386T2 (de)
DK (1) DK203588A (de)
ES (1) ES2061719T3 (de)
FI (1) FI98219C (de)
HU (1) HU204557B (de)
IL (1) IL86058A (de)
MX (1) MX168507B (de)
MY (1) MY103358A (de)
NO (1) NO179046C (de)
NZ (1) NZ224243A (de)
PT (1) PT87230B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634495B1 (fr) * 1988-07-01 1990-10-26 Chambon Pierre Procede de preparation d'une proteine par des levures utilisant un systeme inductible, vecteurs et souches transformees correspondantes
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
EP0462207B1 (de) * 1989-03-06 2001-02-07 Board Of Regents, The University Of Texas System Gegenüber eigenen inhibitoren resistente t-pa mutanten
EP0387380A1 (de) * 1989-03-17 1990-09-19 BEHRINGWERKE Aktiengesellschaft Mutanten von Plasminogenaktivator aus Urin, ihre Herstellung und Verwendung
US5268273A (en) * 1990-12-14 1993-12-07 Phillips Petroleum Company Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
SE9201544L (sv) * 1991-05-31 1992-12-01 Ciba Geigy Ag Saett att framstaella glykosyltransferaser
GB2256197B (en) * 1991-05-31 1995-11-22 Ciba Geigy Ag Yeast as host for expression of heterologous glycosyl transferase enzymes
JPH0823995A (ja) * 1994-07-14 1996-01-30 Green Cross Corp:The 宿主細胞由来のプロテアーゼで低分子化され得る蛋白質の製造方法
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
US6207442B1 (en) * 1997-10-16 2001-03-27 Zymogenetics, Inc. Plasmid construction by homologous recombination

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
US4558010A (en) * 1980-04-03 1985-12-10 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
FI88932C (fi) * 1982-04-15 1993-07-26 Genentech Inc Framstaellning av funktionellt maenskligt urokinasprotein
GR79202B (de) * 1982-05-05 1984-10-22 Genentech Inc
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
US5010003A (en) * 1983-04-25 1991-04-23 Genentech, Inc. Use of yeast homologous signals to secrete heterologous proteins
DE3585097D1 (de) * 1984-02-27 1992-02-20 Green Cross Corp Herstellung menschlicher urokinase.
JPS60256385A (ja) * 1984-05-18 1985-12-18 イーライ・リリー・アンド・カンパニー 酵母においてヘテロローガスポリペプチドを効率よく発現するための方法、ベクターおよび形質転換体
JPS60248181A (ja) * 1984-05-23 1985-12-07 Shiseido Co Ltd 酵母発現ベクタ−
EP0174835A1 (de) * 1984-09-11 1986-03-19 The Upjohn Company Menschlicher Gewebeplasminogenaktivator und rekombinante DNA-Zusammensetzungen
AU5390286A (en) * 1985-01-25 1986-08-13 Sagami Chemical Research Center Stabilized human prourokinase
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
GR861037B (en) * 1985-04-22 1986-07-16 Genentech Inc Novel human tissue plasminogen activator mutants
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
DE19736137C1 (de) * 1997-08-20 1998-10-01 Daimler Benz Ag Verfahren zum Starten eines Verbrennungsmotors

Also Published As

Publication number Publication date
DK203588D0 (da) 1988-04-14
PT87230A (pt) 1988-05-01
CA1341306C (en) 2001-10-23
EP0288435B1 (de) 1994-03-16
NO881615D0 (no) 1988-04-14
IL86058A0 (en) 1988-09-30
JPS63296689A (ja) 1988-12-02
MX168507B (es) 1993-05-27
HUT46360A (en) 1988-10-28
US5175105A (en) 1992-12-29
EP0288435A1 (de) 1988-10-26
HU204557B (en) 1992-01-28
FI881713A0 (fi) 1988-04-13
DE3888386D1 (de) 1994-04-21
NZ224243A (en) 1991-02-26
FI98219B (fi) 1997-01-31
DD274053A5 (de) 1989-12-06
AU604305B2 (en) 1990-12-13
MY103358A (en) 1993-06-30
PT87230B (pt) 1992-08-31
IL86058A (en) 1993-07-08
ATE102994T1 (de) 1994-04-15
FI98219C (fi) 1997-05-12
DE3888386T2 (de) 1994-07-14
NO179046B (no) 1996-04-15
DK203588A (da) 1988-10-16
AU1462688A (en) 1988-10-20
JP2894696B2 (ja) 1999-05-24
NO881615L (no) 1988-10-17
FI881713L (fi) 1988-10-16
ES2061719T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
HUT58798A (en) Process for producing growth factor of parenchimic hepatic celles, the gen for coding this and transformants for producing this factor
DE3851035D1 (de) Interleukin-7.
NO179046C (no) Fremgangsmåte for fremstilling av biologisk aktivt human enkelt kjede urokinase-type plasminogenaktivator
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
NO910719D0 (no) Vektorer og forbindelser for ekspresjon av glykosyleringsmutanter av humant protein c.
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
ATE148167T1 (de) Hybride plasminogenaktivatoren
FI915149A0 (fi) Foerfarande och material foer expression av humant plasminogen i ett eukaryotiskt cellsystem som saknar en laegesspecifik plasminogenaktivator.
EP0290118A3 (de) Fibrinolytisch wirksames Enzym
FI945877A0 (fi) Menetelmä proteiini C:n tuottamiseksi
DE69120315D1 (de) Rekombinante DNA-Expressionsvektoren und DNA-Zusammensetzungen, die Isopenizillin N-Epimerase-Aktivität kodieren
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
EP0232544A3 (de) Verfahren zur Herstellung physiologisch wirksamer Substanzen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2002